Explore › Outcome › youth depressive symptoms
Outcome

youth depressive symptoms

Also known as: Parent-reported youth depressive symptoms (Parent MFQ)
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Sertraline1
conditions
Anxiety Disorders1
populations
Adolescents1
studys
PMC64257331

Findings (27)

None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →
None
improvement

Combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported youth depressive symptoms, while CBT was not, with both COMB and SRT also superior to CBT.

Effect: improvement; COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8

Size: COMB: b= -3.9, t= -3.7; SRT: b= -3.0, t= -2.8
PMC6425733
Finding details → · Paper → · Graph →

Papers (1)